Feasibility of Delivering Mesenchymal Stem Cells via Catheter to the Proximal End of the Lesion Artery in Patients with Stroke in the Territory of the Middle Cerebral Artery

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cell Transplantation

• Publication date

  2013-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3727/096368912X658818PMID 23127560
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Beyond the Time Window of Intravenous Thrombolysis: Standing by or by Stenting?

  2012cited by this paper
• Adventitial Delivery of an Allogeneic Bone Marrow–Derived Adherent Stem Cell in Acute Myocardial Infarction: Phase I Clinical Study

  2012cited by this paper
• Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

  2011cited by this paper
• Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy

  2011cited by this paper
• Outcome of Patients With ≥70% Symptomatic Intracranial Stenosis After Wingspan Stenting

  2011cited by this paper
• Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke.

  2011cited by this paper
• Have Medical Therapy and Stenting Been Fairly Compared? A Repercussion upon Termination of Recruitment in the SAMMPRIS Trial

  2011cited by this paper
• Effects of age and heart failure on human cardiac stem cell function.

  2011cited by this paper
• Intranasal delivery of stem cells to the brain

  2011cited by this paper
• A Long‐Term Follow‐Up Study of Intravenous Autologous Mesenchymal Stem Cell Transplantation in Patients With Ischemic Stroke

  2010cited by this paper
• Intraarterial autologous implantation of adult stem cells for patients with Parkinson disease.

  2010cited by this paper
• Biodistribution of Neural Stem Cells After Intravascular Therapy for Hypoxic–Ischemia

  2010cited by this paper
• Immunosuppressive properties of human umbilical cord‐derived mesenchymal stem cells: role of B7‐H1 and IDO

  2010cited by this paper
• Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

  2009cited by this paper
• Early tissue distribution of bone marrow mononuclear cells after intra-arterial delivery in a patient with chronic stroke.

  2009cited by this paper
• Transplanted Neural Precursors Enhance Host Brain-Derived Myelin Regeneration

  2009cited by this paper
• Concise Review: Wharton's Jelly‐Derived Cells Are a Primitive Stromal Cell Population

  2008cited by this paper
• Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

  2008cited by this paper
• Dual-Modality Monitoring of Targeted Intraarterial Delivery of Mesenchymal Stem Cells After Transient Ischemia

  2008cited by this paper
• Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction

  2007cited by this paper
• Human First‐Trimester Fetal MSC Express Pluripotency Markers and Grow Faster and Have Longer Telomeres Than Adult MSC

  2007cited by this paper
• Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

  2006cited by this paper
• Subtypes and One-Year Survival of First-Ever Stroke in Chinese Patients: The Nanjing Stroke Registry

  2006cited by this paper
• Transcoronary transplantation of progenitor cells after myocardial infarction.

  2006cited by this paper
• Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials.

  2006influential reference
• Host factors that impact the biodistribution and persistence of multipotent adult progenitor cells.

  2006cited by this paper
• Autologous mesenchymal stem cell transplantation in stroke patients

  2005cited by this paper
• Acute Stroke Care in the US: Results from 4 Pilot Prototypes of the Paul Coverdell National Acute Stroke Registry

  2005cited by this paper
• Neurotransplantation of Fetal Porcine Cells in Patients with Basal Ganglia Infarcts: A Preliminary Safety and Feasibility Study

  2005cited by this paper
• Pipecolic acid: A diagnostic marker in pyridoxine‐dependent epilepsy

  2005cited by this paper
• Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.

  2004cited by this paper
• Treatment of neural injury with marrow stromal cells.

  2002cited by this paper
• Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)

  2002cited by this paper
• Therapeutic Benefit of Intravenous Administration of Bone Marrow Stromal Cells After Cerebral Ischemia in Rats

  2001influential reference
• Therapeutic Benefit of Intravenous Administration of Bone Marrow Stromal Cells After Cerebral Ischemia in Rats

  2001cited by this paper

• Efficacy and safety of mesenchymal stem cells for cerebral infarction: A meta-analysis

  2026cites this paper
• Stroke: Epidemiology, Risk Factors, Signaling Pathways, and Clinical Management

  2025cites this paper
• Intra-Arterial Stem Cell Injection for Treating Various Diseases: A New Frontier in Interventional Radiology

  2025cites this paper
• Mesenchymal stem cell for hemorrhagic stroke: A clinical review

  2025cites this paper
• Overview of Cellular Therapeutics Clinical Trials: Advances, Challenges, and Future Directions

  2025cites this paper
• Clinical trials and advanced MRI techniques with stem cell therapy for ischemic stroke: present and future perspectives

  2025cites this paper
• The promise of stem cell therapies for cellular recovery after stroke

  2025cites this paper
• Intrathecal versus intravenous umbilical cord mesenchymal stem cells for ischemic stroke sequelae

  2025cites this paper
• Clinical diagnostic and therapeutic guidelines for ischemic stroke neurorestoration (2024 China version)

  2025cites this paper
• Mesenchymal stem cells in neurological disorders: Insights from clinical trials

  2025cites this paper
• Revolutionizing Stroke Recovery: Unveiling the Promise of Stem Cell Therapy

  2024cites this paper
• Clinical state and future directions of stem cell therapy in stroke rehabilitation.

  2024cites this paper
• Efficacy and safety of mesenchymal stem cell therapies for ischemic stroke: a systematic review and meta-analysis

  2024cites this paper
• Mining human clinical waste as a rich source of stem cells for neural regeneration

  2024cites this paper
• Stem cell therapy as a promising approach for ischemic stroke treatment

  2024cites this paper
• The Role of Stem Cells as Therapeutics for Ischaemic Stroke

  2024cites this paper
• Stem Cell Implants: Emerging Innovation for Stroke Recovery

  2023cites this paper
• Research progress in clinical trials of stem cell therapy for stroke and neurodegenerative diseases

  2023cites this paper
• Comparison of the Administration Route of Stem Cell Therapy for Ischemic Stroke: A Systematic Review and Meta-Analysis of the Clinical Outcomes and Safety

  2023cites this paper
• Role of Mesenchymal Stem/Stromal Cells in Modulating Ischemia/Reperfusion Injury: Current State of the Art and Future Perspectives

  2023cites this paper
• A review and meta-analysis of stem cell therapies in stroke patients: effectiveness and safety evaluation

  2023cites this paper
• Administration of stem cells against cardiovascular diseases with a focus on molecular mechanisms: Current knowledge and prospects.

  2023cites this paper
• Stem Cell Therapy for Acute/Subacute Ischemic Stroke with a Focus on Intraarterial Stem Cell Transplantation: From Basic Research to Clinical Trials

  2022cites this paper
• The role of mesenchymal stem cell transplantation for ischemic stroke and recent research developments

  2022cites this paper
• Clinical outcome and safety of stem cell therapy for ischemic stroke: A systematic review and meta-analysis

  2022cites this paper
• Researches and Applications of Stem Cell Secretome

  2021cites this paper
• Mechanism of White Matter Injury and Promising Therapeutic Strategies of MSCs After Intracerebral Hemorrhage

  2021cites this paper
• Mesenchymal Stem Cells for Neurological Disorders

  2021cites this paper
• Mesenchymal Stromal Cells Perspective: New Potential Therapeutic for the Treatment of Neurological Diseases

  2021cites this paper
• Strategies to Improve the Quality and Freshness of Human Bone Marrow-Derived Mesenchymal Stem Cells for Neurological Diseases

  2021cites this paper
• Modulating poststroke inflammatory mechanisms: Novel aspects of mesenchymal stem cells, extracellular vesicles and microglia

  2021cites this paper
• Clinical neurorestorative cell therapies for stroke.

  2021cites this paper
• Sox9 Is Crucial for Mesenchymal Stem Cells to Enhance Cutaneous Wound Healing

  2021cites this paper
• Contribution of Human Trophoblast Progenitor Cells to Neurogenesis in Rat Focal Cerebral Ischemia Model

  2021cites this paper
• Stem Cell Culture System Simulating Continuous Fluctuating Pressure in vivo

  2021cites this paper
• Stem Cell Therapy for Vascular Diseases: State of the Evidence and Clinical Applications

  2021influential citation
• Caffeine and Its Neuroprotective Role in Ischemic Events: A Mechanism Dependent on Adenosine Receptors

  2021cites this paper
• Super selective intra-arterial cerebral infusion of modern chemotherapeutics after blood–brain barrier disruption: where are we now, and where we are going

  2020cites this paper
• Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential

  2020cites this paper
• Fighting the War Against COVID-19 via Cell-Based Regenerative Medicine: Lessons Learned from 1918 Spanish Flu and Other Previous Pandemics

  2020cites this paper
• Clinical Trials of Stem Cell Therapy for Cerebral Ischemic Stroke

  2020cites this paper
• Current Status and Future Prospects of Perinatal Stem Cells

  2020cites this paper
• Clinical neurorestorative cell therapies: Developmental process, current state and future prospective

  2020cites this paper
• The therapeutic potential of exogenous adult stem cells for the injured central nervous system

  2020cites this paper
• Endovascular Selective Intra-Arterial Infusion of Mesenchymal Stem Cells Loaded With Delta-24 in a Canine Model.

  2020cites this paper
• What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment?

  2020cites this paper
• Microcatheter delivery of neurotherapeutics: compatibility with mesenchymal stem cells.

  2020cites this paper
• Stem Cell Delivery Techniques for Stroke and Peripheral Artery Disease

  2020cites this paper
• Research trends of stem cells in ischemic stroke from 1999 to 2018: A bibliometric analysis.

  2020cites this paper
• Neuroinflammation as a target for treatment of stroke using mesenchymal stem cells and extracellular vesicles

  2019cites this paper
• Regenerative Capacity of Adipose Derived Stem Cells (ADSCs), Comparison with Mesenchymal Stem Cells (MSCs)

  2019cites this paper
• Perinatal Stem Cells

  2019cites this paper
• Developing an in vitro Stroke Model for Studying Adipose Stem Cells' Paracrine Effect on Neuronal Recovery After Ischemia

  2019cites this paper
• Therapeutic Application of Perinatal Mesenchymal Stem Cells in Nervous System Diseases

  2019cites this paper
• The Efficacy of Near-Infrared Spectroscopy Monitoring in Carotid Endarterectomy: A Prospective, Single-Center, Observational Study

  2018cites this paper
• Intrathecal Injection of Allogenic Bone Marrow-Derived Mesenchymal Stromal Cells in Treatment of Patients with Severe Ischemic Stroke: Study Protocol for a Randomized Controlled Observer-Blinded Trial

  2018cites this paper
• [Cell therapy for ischemic stroke. Results of clinical trials and perspectives of clinical application in the Russian Federation].

  2018cites this paper
• The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke

  2018cites this paper
• Intra-Arterial Delivery of Cell Therapies for Stroke.

  2018cites this paper
• Pharmacological approaches promoting stem cell-based therapy following ischemic stroke insults

  2018cites this paper
• Mechanism and application of stem cell transplantation in the treatment of ischemic stroke

  2018cites this paper
• Extracellular vesicles in mesenchymal stromal cells: A novel therapeutic strategy for stroke

  2018cites this paper
• Placenta-Derived Cells for Acute Brain Injury

  2018cites this paper
• Reliability of behavioral tests in the middle cerebral artery occlusion model of rat

  2018cites this paper
• Stem cell‐based cell therapy for neuroprotection in stroke: A review

  2018cites this paper
• Wharton’s Jelly-Derived Mesenchymal Stem Cell Transplantation in a Patient with Hypoxic-Ischemic Encephalopathy

  2018cites this paper
• Cell-Based Therapy Using Umbilical Cord Blood for Novel Indications in Regenerative Therapy and Immune Modulation: An Updated Systematic Scoping Review of the Literature.

  2017cites this paper
• Stem cell therapies in age-related neurodegenerative diseases and stroke.

  2017cites this paper
• Analyses of the Dual Immune Roles Cytokines Play in Ischemic Stroke

  2017cites this paper
• Safety and effectiveness of stem cell therapies in early-phase clinical trials in stroke: a systematic review and meta-analysis

  2017cites this paper
• China's landscape in regenerative medicine.

  2017cites this paper
• Phase I/II randomized controlled trial of autologous bone marrow-derived mesenchymal stem cell therapy for chronic stroke

  2017cites this paper
• Umbilical cord mesenchymal stromal cell transplantations: A systemic analysis of clinical trials.

  2017cites this paper
• Developing Clinical Guidelines to Treat Stroke with Stem Cells Part I: Acute and Sub Acute Ischemic Stroke

  2017cites this paper
• Applications of Optogenetics as Alternative Treatment for Neurological Diseases

  2017cites this paper
• Permeability and distribution of nerve growth factor in the brain of neonatal rats by periphery venous injection in hypoxic-ischemic state

  2016cites this paper
• Co-transplantation of Endothelial Progenitor Cells and Neural Progenitor Cells for Treating Ischemic Stroke in a Mouse Model

  2016influential citation
• Mesenchymal stromal cell therapy in ischemic stroke

  2016cites this paper
• Mesenchymal Stem Cells for Ischemic Stroke: Progress and Possibilities.

  2016cites this paper
• Bone marrow mesenchymal stem cell therapy in ischemic stroke: mechanisms of action and treatment optimization strategies

  2016cites this paper
• A Detailed Assessment of Varying Ejection Rate on Delivery Efficiency of Mesenchymal Stem Cells Using Narrow‐Bore Needles

  2016cites this paper
• Safety and efficacy of cell therapies administered in the acute and subacute stages after stroke: a meta-analysis.

  2016cites this paper
• Mesenchymal Stem/Stromal Cells From Neonatal Tissues

  2016cites this paper
• Human umbilical cord mesenchymal stem cells: an overview of their potential in cell-based therapy

  2015cites this paper
• Cord blood for brain injury.

  2015cites this paper
• Stem Cells and Regenerative Medicine: Myth or Reality of the 21th Century

  2015cites this paper
• Expected applications of the endometrial stem cells in clinical practice

  2015cites this paper
• The Dark Side of the Force – Constraints and Complications of Cell Therapies for Stroke

  2015cites this paper
• Isolation and proliferation of umbilical cord tissue derived mesenchymal stem cells for clinical applications

  2015cites this paper
• Neuroprotection for ischaemic stroke: current status and challenges.

  2015cites this paper
• Intra-arterial Approaches to Stem Cell Therapy for Ischemic Stroke

  2015cites this paper
• Transplantation of Adipose-Derived Stem Cells in Stroke

  2015cites this paper
• Clinical neurorestorative progress in stroke

  2015cites this paper
• Cell based therapies for ischemic stroke: from basic science to bedside.

  2014cites this paper
• Keep warm and get success: the role of postischemic temperature in the mouse middle cerebral artery occlusion model.

  2014cites this paper
• Neurorestorative Therapy for Stroke

  2014cites this paper
• The Yin and Yang of Innate Immunity in Stroke

  2014cites this paper
• Stem Cell-Based Therapies for Ischemic Stroke

  2014cites this paper
• Intra-Arterial Bone Marrow Mononuclear Cell Transplantation Correlates with GM-CSF, PDGF-BB, and MMP-2 Serum Levels in Stroke Patients: Results from a Clinical Trial

  2014cites this paper
• Clinical trials of amyloid-based immunotherapy for Alzheimer's disease: end of beginning or beginning of end?

  2013cites this paper